Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.

Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked over 40 pharma leaders, do you support a generic drug user fee for industry?

Yes 61%
No 39%

Talk to us:
editor@pharmexeceurope.com

Advertise with us: jgray@advanstar.com


6 December, 2011
In this Issue
Achieving that First $ Billion
Mauli Teli, Vinita Vasanth and Dinkar Saran believe that many small pharmaceutical companies have the opportunity to catapult themselves beyond the $1 billion revenue mark in the next five to ten years... More...
Lipitor Reaches the Patient Cliff
On Nov. 30, 2011, the patent for Lipitor, the cholesterol-lowering drug that defined the term “blockbuster,” expired. Over its lifetime, it is estimated that Lipitor generated over $100 billion in sales for its parent company, Pfizer, since its introduction in 1997. Amy Ritter asks what happens now... More...
Merck and Merck Face Off
Stephanie Sutton reports on Merck KGaA's legal wrangle with US rival Merck & Co. over Facebook... More...
Elan and Cambridge University Launch New Research Centre
Elan and the University of Cambridge have launched a center for innovation and drug discovery that will focus on translational research into therapies for Alzheimer’s and Parkinson’s diseases... More...
Also in this issue…
GSK's Andrew Witty: Concerns for Europe
Let's Fight Adulteration with Information
The Real Way to Lean: Suck Out the IT Fat

Product Profile
NNIT

GxP Cloud - business enablement for Life Sciences only
NNIT has built an enhanced cloud allowing Life Science companies to enjoy all the benefits from cloud computing and still fulfill the GxP requirement.
Read more


 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail

at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK